Lasmiditan is effective in the acute treatment of migraine in patients with insufficient response to triptans: Findings from the centurion study

Category Primary study
JournalNeurology
Year 2021
This article has no abstract
Epistemonikos ID: 3eaec14e74591c20feee52a14394729e0f041b57
First added on: Feb 13, 2025